FULC
Fulcrum Therapeutics Inc
NASDAQ: FULC · HEALTHCARE · BIOTECHNOLOGY
$7.15
-3.90% today
Updated 2026-04-29
Market cap
$522.15M
P/E ratio
—
P/S ratio
2.66x
EPS (TTM)
$-1.18
Dividend yield
—
52W range
$4 – $16
Volume
1.2M
Fulcrum Therapeutics Inc (FULC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |